Physical Activity Intervention for Older Patients During Chemotherapy for Colorectal Cancer
The Impact of a Physical Activity Intervention in Older Patients Undergoing Adjuvant Chemotherapy for Colorectal Cancer: a Randomized, Controlled Trial
1 other identifier
interventional
36
1 country
1
Brief Summary
This study will see if patient who undergo a physical activity intervention called Walk With Ease report experiencing less fatigue and a higher quality of life during chemotherapy for colorectal cancer than those who do not participate in this intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable colorectal-cancer
Started Jun 2014
Longer than P75 for not_applicable colorectal-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 17, 2014
CompletedFirst Posted
Study publicly available on registry
July 16, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 18, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 18, 2019
CompletedMay 1, 2020
November 1, 2019
5.3 years
June 17, 2014
April 29, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To measure the change in fatigue after three months between the intervention and control arm
The investigators will compare the change in fatigue from baseline to 3 months between Intervention and Control arms as measured via PROMIS®-Fatigue.
Three Months
Secondary Outcomes (9)
To measure changes in physical function at baseline between the intervention and control groups.
4 to 24 weeks
To measure adherence to the physical activity intervention
One Year
To measure the difference in p16INK4a levels before and after chemotherapy in the control and intervention groups
One Year
To measure the change in muscle mass measurements before and after chemotherapy between the intervention and control arms
One Year
To measure the association of p16INK4a and muscle mass with any differences in fatigue o physical function or QOL during chemotherapy
Six months
- +4 more secondary outcomes
Study Arms (2)
Control
NO INTERVENTIONThis group will be receiving adjuvant chemotherapy for colorectal cancer. They will not participate in the Walk With Ease program. They will be followed up using standard of care.
Intervention
EXPERIMENTALThis group will be receiving adjuvant chemotherapy for colorectal cancer. They will participate in the Walk With Ease (WWE) program during the course of their chemotherapy treatment. They will be requested to initiate the WWE starting on Day 1 of adjuvant chemotherapy. Participants are asked to walk at a safe and comfortable pace, increasing their minutes per day at a rate they can sustain, with the ultimate goal of 30 minutes/day for at least 5 days/week. They are asked to maintain a daily walking log that is provided to them, entering total minutes per day. Participants will be asked to do the walking program independently (self-directed, not in a formal group with an instructor) throughout chemotherapy.
Interventions
A self-directed walking intervention developed by the Arthritis Foundation. The intervention is a workbook that coaches participants through walking regularly at a safe, comfortable pace with the ultimate goal of walking at least 30 minutes a day five days a week.
Eligibility Criteria
You may qualify if:
- ≥ Age 60 years (no upper age limit)
- Diagnosis of stage II-III colon or rectal cancer planned for treatment with adjuvant chemotherapy scheduled as part of standard treatment
- Able to read English (required for CGA and other surveys administered)
- Approval from their treating physician to engage in moderate-intensity physical activity
- Patient-assessed ability to walk and engage in moderate physical activity
- Signed, IRB-approved written informed consent
You may not qualify if:
- Other active, invasive malignancy requiring ongoing therapy or expected to require systemic therapy
- Already walking or engaging in other physical activity \>120 minutes per week as documented via subject self-report
- Unable to walk or engage in moderate-intensity physical activity
- One or more significant medical conditions that in the physician's judgment preclude participation in the walking intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
Related Publications (1)
Williams GR, Nyrop KA, Deal AM, Muss HB, Sanoff HK. Self-directed physical activity intervention in older adults undergoing adjuvant chemotherapy for colorectal cancer: Design of a randomized controlled trial. Contemp Clin Trials. 2015 May;42:90-7. doi: 10.1016/j.cct.2015.03.008. Epub 2015 Mar 28.
PMID: 25827253DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hy Muss, MD
UNC Lineberger Comprehensive Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2014
First Posted
July 16, 2014
Study Start
June 1, 2014
Primary Completion
September 18, 2019
Study Completion
September 18, 2019
Last Updated
May 1, 2020
Record last verified: 2019-11